JAGS REPORT 3/1 AEGIS REINTERATES BUY ON AMRN WITH $35 TARGET. // LINK //
GO TO GOOGLE AND PUT IN " Jags Report Aegis AMRN " if You Want to Confirm Link.
Amarin Co. plc Given “Buy” Rating at Aegis (AMRN)
Posted by Seth Barnet on Mar 1st, 2013 // No Comments
Amarin Co. plc (NASDAQ: AMRN)‘s stock had its “buy” rating reiterated by equities research analysts at Aegis in a research note issued to investors on Friday. They currently have a $35.00 price target on the stock.
The analysts wrote, “Yesterday afternoon, Amarin released 4Q and FY2012 financial results. The firm reported a net loss of $0.07 per share for 4Q 2012 and a net loss of $1.24 per share for FY 2012, vs. our estimate of a net loss of $0.30 per share for 4Q 2012 and a net loss of $1.51 per share for the full year. The improved bottom line was driven primarily by a higher-than-expected gain on change in fair value of derivative liability.
In anticipation of the approval of the drug for use in mixed dyslipidemia late in 2013, we are reiterating our Buy rating and $35.00 price target on Amarin shares.”